Enalare Therapeutics Announces Closing of Successful Seed Funding Round

Feb 2, 2021

The Company Raises $10 Million to Expand Its Operations and Prepare to Conduct Pivotal Studies of Lead Drug Candidate ENA-001



PRINCETON, N.J. - February 2, 2021 - (Newswire.com)

Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing novel therapies for life-threatening acute respiratory and critical care conditions, announced today that it has successfully closed its seed funding round of $10 million. The offering was met with significant enthusiasm and exceeded the original target, attracting a wide range of experienced biopharmaceutical investors, including two funds that each contributed more than $3 million. 

"We are very pleased to have accomplished this important milestone for the Company and to see investor confidence in ENA-001 as a treatment for patients experiencing life-threatening acute respiratory depression," stated Herm Cukier, Executive Chairman, President, and CEO of Enalare Therapeutics.  "We are well-positioned to move forward with our plans to further capitalize the Company and achieve significant development milestones in the year ahead."

"This successful seed round is another validation of the potential for Enalare's novel drug compounds," stated Daniel Motto, Enalare's Chief Operating Officer.  "We have already started to deploy these funds to grow our R&D organization, advance the clinical programs, and initiate advanced formulation work to expand our product offerings."

About Enalare Therapeutics Inc.

Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from acute respiratory and critical care conditions including respiratory depression caused by drug overdose, post-surgery, and pathogens such as COVID-19.  The Company is planning to initiate pivotal studies for its lead compound ENA-001 in the near term.

###

Contact:

Morgan Wagner
Investor Relations
[email protected]




Press Release Service by Newswire.com

Original Source: Enalare Therapeutics Announces Closing of Successful Seed Funding Round

More News

Binance Lost Over $6 Billion in Crypto Hack. Here’s What to Know.
Oct 31, 2026
Binance Lost Over $6 Billion in Crypto Hack. Here’s What to Know.

Hackers made off with around $6 billion in digital currency in what could be the biggest crypto heist in history. Binance said it will cover the losses.

How Binance’s $6.3 Billion Hack Went Down
Oct 31, 2026
How Binance’s $6.3 Billion Hack Went Down

A war room. A global conference call. A founder who live-posted about the largest crypto heist in history. Inside a frantic 24 hours at the world’s biggest crypto exchange.

Judge Tosses Trump’s $10 Billion Suit Against The Wall Street Journal
Oct 31, 2026
Judge Tosses Trump’s $10 Billion Suit Against The Wall Street Journal

The defamation suit focused on an article about a birthday note to Jeffrey Epstein. It was the president’s second attempt to claim the publication had acted with actual malice.

The New Hot Job in Law Doesn’t Require a J.D.
Oct 31, 2026
The New Hot Job in Law Doesn’t Require a J.D.

Big law firms, legal tech vendors, and in-house legal departments at companies like Microsoft and Nvidia are all hiring legal engineers, a new position for lawyers with A.I. skills.

Pick Another Protein? Americans Still Want Beef, Despite the Price.
Oct 31, 2026
Pick Another Protein? Americans Still Want Beef, Despite the Price.

After chicken, consumers are buying more beef, while pork, turkey and soy products remain flat.

The U.S. Becomes a Global Hub for Horse Racing
Oct 31, 2026
The U.S. Becomes a Global Hub for Horse Racing

More horses from overseas are competing in America’s marquee events, as the sport enjoys a renaissance.

Why Did So Many People File Early for Social Security Last Year?
Oct 31, 2026
Why Did So Many People File Early for Social Security Last Year?

Experts point to well-publicized turmoil at the government agency last year as a potential spark.

Strengthening party self-governance and integrity for economic growth
Oct 31, 2026
Strengthening party self-governance and integrity for economic growth

The 20th Central Committee of the Communist Party of China convened its fifth plenary session in Beijing from October 26 to 29, 2026, where it deliberated and adopted the Resolution of the Central Committee of the Communist Party of China on Certain Major Issues concerning Persevering with Full and Rigorous Party Self-Governance.

70 years on, why global buyers keep coming back to Canton Fair
Oct 31, 2026
70 years on, why global buyers keep coming back to Canton Fair

70 years on, why global buyers keep coming back to Canton Fair

China's manufacturing PMI at 49.3, non-manufacturing PMI at 49.7
Oct 31, 2026
China's manufacturing PMI at 49.3, non-manufacturing PMI at 49.7

China's purchasing managers' index for the manufacturing sector came in at 49.3 in October, down 0.8 percentage points from the previous month, while the non-manufacturing PMI stood at 49.7, down 0.5 percentage points.

How One Country Became the Unlikely Crossroads of the Global A.I. Boom
Oct 31, 2026
How One Country Became the Unlikely Crossroads of the Global A.I. Boom

In Malaysia, U.S. and Chinese tech giants are pouring billions into vast data centers, straining local resources and testing the limits of Washington’s restrictions on advanced chips.

Wanted: New Central Bank Chief. Expertise and Political Acumen Required.
Oct 31, 2026
Wanted: New Central Bank Chief. Expertise and Political Acumen Required.

The looming departure of the European Central Bank’s president, Christine Lagarde, has set in motion a high-stakes search for her successor.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Manage The Numbers

Manage The Numbers is the world’s fastest-growing finance news website, featuring the latest money and market news, along with in-depth analysis so you can make the best decision.

Newsletter